Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Equity Income: 2019-2023

Historic Equity Income for Caribou Biosciences (CRBU) over the last 4 years, with Dec 2023 value amounting to -$6,000.

  • Caribou Biosciences' Equity Income fell 250.00% to -$14,000 in Q3 2024 from the same period last year, while for Sep 2024 it was -$129,000, marking a year-over-year decrease of 126.32%. This contributed to the annual value of -$6,000 for FY2023, which is 95.49% up from last year.
  • According to the latest figures from FY2023, Caribou Biosciences' Equity Income is -$6,000, which was up 95.49% from -$133,000 recorded in FY2022.
  • Caribou Biosciences' Equity Income's 5-year high stood at $2.3 million during FY2019, with a 5-year trough of -$733,000 in FY2020.
  • Moreover, its 2-year median value for Equity Income was -$69,500 (2022), whereas its average is -$69,500.
  • Per our database at Business Quant, Caribou Biosciences' Equity Income crashed by 131.95% in 2020 and then surged by 95.49% in 2023.
  • Yearly analysis of 4 years shows Caribou Biosciences' Equity Income stood at $2.3 million in 2019, then slumped by 131.95% to -$733,000 in 2020, then reached -$133,000 in 2022, then surged by 95.49% to -$6,000 in 2023.